About Uvic Steratics
Uvic Steratics is a company based in Seoul (South Korea) founded in 2018.. Uvic Steratics has raised $17.6 million across 1 funding round from investors including Korean Development Bank, Atinum Investment and Solidus Investment. Uvic Steratics operates in a competitive market with competitors including Accutar Biotechnology, Plexium, Photys Therapeutics, Lycia Therapeutics and Outruntx, among others.
- Headquarter Seoul, South Korea
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Ubic Therapeutics Co., Ltd.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$17.6 M (USD)
in 1 rounds
-
Latest Funding Round
$17.6 M (USD), Series B
Dec 24, 2024
-
Investors
Korean Development Bank
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Uvic Steratics
Uvic Steratics has successfully raised a total of $17.6M through 1 strategic funding round. The most recent funding activity was a Series B round of $17.6 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series B — $17.6M
-
First Round
First Round
(24 Dec 2024)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2024 | Amount | Series B - Uvic Steratics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Uvic Steratics
Uvic Steratics has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Korean Development Bank, Atinum Investment and Solidus Investment. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
A global venture platform focused on biotech and healthcare startups is operated.
|
Founded Year | Domain | Location | |
|
VC firm investing in geographies such as South Korea
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Uvic Steratics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Uvic Steratics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Uvic Steratics Comparisons
Competitors of Uvic Steratics
Uvic Steratics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Accutar Biotechnology, Plexium, Photys Therapeutics, Lycia Therapeutics and Outruntx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-assisted tools for drug discovery are developed.
|
|
| domain | founded_year | HQ Location |
Integrated chemistry service provider
|
|
| domain | founded_year | HQ Location |
Protein-based small molecules are developed to treat human diseases.
|
|
| domain | founded_year | HQ Location |
Protein degradation drugs are developed for cancer and autoimmune diseases.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for cancer treatment
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Uvic Steratics
Frequently Asked Questions about Uvic Steratics
When was Uvic Steratics founded?
Uvic Steratics was founded in 2018 and raised its 1st funding round 6 years after it was founded.
Where is Uvic Steratics located?
Uvic Steratics is headquartered in Seoul, South Korea.
Who is the current CEO of Uvic Steratics?
Servo Optical is the current CEO of Uvic Steratics.
Is Uvic Steratics a funded company?
Uvic Steratics is a funded company, having raised a total of $17.6M across 1 funding round to date. The company's 1st funding round was a Series B of $17.6M, raised on Dec 24, 2024.
What does Uvic Steratics do?
Founded in 2018 and based in Seoul, South Korea, Uvic Steratics operates in the biotechnology sector. Anti-cancer drugs are developed using an inhibitor technology that targets disease-related proteins for degradation. This approach involves binding the proteins near E3 ligases to activate the cellular proteolysis system, aiming for therapeutic effects through protein breakdown. Operations focus on advancing this chimera-based method for oncology applications.
Who are the top competitors of Uvic Steratics?
Uvic Steratics's top competitors include Plexium, Photys Therapeutics and Accutar Biotechnology.
Who are Uvic Steratics's investors?
Uvic Steratics has 6 investors. Key investors include Korean Development Bank, Atinum Investment, Solidus Investment, Shinyoung Asset Management, and Mint Venture Partners.